Lead Product(s) : Voclosporin
Therapeutic Area : Ophthalmology
Study Phase : Phase II/ Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Last patient study visit has occurred in the Phase 2/3 AUDREY™ clinical study evaluating voclosporin ophthalmic solution (VOS) for the potential treatment of dry eye syndrome (DES).
Product Name : Lupkynis
Product Type : Peptide
Upfront Cash : Inapplicable
September 28, 2020
Lead Product(s) : Voclosporin
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II/ Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Voclosporin
Therapeutic Area : Ophthalmology
Study Phase : Phase II/ Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Aurinia has completed enrollment for the Phase 2/3 AUDREY™ clinical trial evaluating voclosporin ophthalmic solution (VOS) for the potential treatment of dry eye syndrome (DES), a chronic disease estimated to affect more than 16 million people in the U...
Product Name : Lupkynis
Product Type : Peptide
Upfront Cash : Inapplicable
June 22, 2020
Lead Product(s) : Voclosporin
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II/ Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Voclosporin
Therapeutic Area : Ophthalmology
Study Phase : Phase II/ Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Aurinia Announces Outcome of AUDREY™ Clinical Trial in Dry Eye Syndrome
Details : Phase 2/3 AUDREY™ clinical study evaluating voclosporin ophthalmic solution (VOS) for the potential treatment of dry eye syndrome (DES) did not achieve statistical significance on the primary endpoint of ≥ 10mm improvement in Schirmer Tear Test (STT)...
Product Name : Lupkynis
Product Type : Peptide
Upfront Cash : Inapplicable
February 11, 2020
Lead Product(s) : Voclosporin
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II/ Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable